C.M. Bidwell & Associates’s West Pharmaceutical WST Stock Holding History

C.M. Bidwell & Associates’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-620	Closed	-$255K	–	568
2022 Q1	$255K	Sell	620 -304	-33%	-$119K	0.17%	115
2021 Q4	$433K	Sell	924 -23	-2%	-$9.9K	0.27%	60
2021 Q3	$402K	Sell	947 -280	-23%	-$118K	0.27%	59
2021 Q2	$441K	Buy	1,227 +76	+7%	+$25.1K	0.29%	54
2021 Q1	$324K	Buy	1,151 +3	+0.3%	+$859	0.24%	63
2020 Q4	$325K	Sell	1,148 -122	-10%	-$34.2K	0.27%	56
2020 Q3	$349K	Buy	1,270 +631	+99%	+$167K	0.32%	51
2020 Q2	$145K	Buy	+639	New	+$126K	0.13%	164

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

C.M. Bidwell & Associates's WST Position: Q2 2022 in Review

C.M. Bidwell & Associates sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 620 shares — an estimated $255K sold.

C.M. Bidwell & Associates first reported a position in WST in Q2 2020 and held it in 8 quarters. The position peaked at $441K in Q2 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

C.M. Bidwell & Associates reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
C.M. Bidwell & Associates sold 620 West Pharmaceutical shares in Q2 2022, an estimated $255K.
C.M. Bidwell & Associates first reported a position in West Pharmaceutical in Q2 2020 and held it in 8 quarters.
C.M. Bidwell & Associates's West Pharmaceutical position peaked at $441K in Q2 2021.
655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.